Hyperbaric Oxygen Therapy (HBOT)
This article is a placeholder. Only its topic and title are committed at this stage; the substantive body will be drafted in a future cycle of the engine.
Intermittent 100% oxygen at 1.5–2.5 ATA, typically in 60-session protocols, with the Tel Aviv Aviv Clinics Efrati cognitive-and-telomere trials as the foundational human evidence. Distinguishes hard-chamber clinical HBOT from soft-chamber consumer chambers (entirely different physics, oxygen partial pressure, and evidence base).